We collect cookies to analyze our website traffic and performance; we never collect any personal data. Cookie Policy
Accept
The Tycoon Herald
  • Trending
  • World
  • Politics
  • Business
    • Business
    • Economy
    • Real Estate
    • Money
    • Crypto / NFT
  • Innovation
  • Lifestyle
    • Lifestyle
    • Food
    • Travel
    • Fashion
    • Leadership
  • Health
  • Sports
  • Entertainment
Reading: Pharmaron Beijing Says Profit Rose Amid U.S., UK Expansion
Sign In
The Tycoon HeraldThe Tycoon Herald
Font ResizerAa
Search
  • Trending
  • World
  • Politics
  • Business
    • Business
    • Economy
    • Real Estate
    • Money
    • Crypto / NFT
  • Innovation
  • Lifestyle
    • Lifestyle
    • Food
    • Travel
    • Fashion
    • Leadership
  • Health
  • Sports
  • Entertainment
Have an existing account? Sign In
Follow US
© Tycoon Herald. All Rights Reserved.
Pharmaron Beijing Says Profit Rose Amid U.S., UK Expansion
The Tycoon Herald > Business > Pharmaron Beijing Says Profit Rose Amid U.S., UK Expansion
BusinessMoney

Pharmaron Beijing Says Profit Rose Amid U.S., UK Expansion

Tycoon Herald
By Tycoon Herald 3 Min Read Published January 24, 2022
Share
SHARE

Pharmaron Beijing’s shares trade in Hong Kong and Shenzhen. Photographer: Roy Liu/Bloomberg

© 2020 Bloomberg Finance LP

Pharmaron Beijing, a China-based pharmaceutical research services company led by billionaire Lou Boliang, expects profit earned in the year to Dec. 31 to have climbed by as much as 45% to 1.7 billion yuan, or about $265 million, amid rising revenue and international expansion.

Revenue is expected to have grown by 43% to 46% over 2020 to as much as 7.49 billion yuan, the company said in a Hong Kong Stock Exchange filing on Friday after the close of trade. Net profit will reach 1.58 billion yuan to 1.7 billion yuan, compared with 1.17 billion yuan a year earlier, Pharmaron said.

Pharmaron has been expanding through the acquisition of a global network. The Beijing-headquartered company bought contract researcher Absorption Systems of Pennsylvania for $137.5 million in 2020, and paid $120 million for a research center owned by AbbVie Inc. in Liverpool in 2021. Earlier this month, it announced the purchase Aesica Pharmaceuticals, a supplier of active pharmaceutical ingredients located in Newcastle, from the UK’s Recipharm group. It didn’t say how much it paid for Aesica. Pharmaron employs 12,000 people globally; 80% of its business is denominated in U.S. dollars.

The company is chaired by Lou Boliang, an American citizen with an estimated fortune worth $1.2 billion on the Forbes Real-Time Billionaires List today. Lou Boliang received his M.S. degree in 1986 and Ph.D. in organic chemistry in 1989 at the Shanghai Institute of Organic Chemistry. Lou did post-doctoral research at the University of Montreal in 1990-1994. Lou worked at life sciences and biotech companies including Cytel and Ontogen before co-founding Pharmaron in 2004. His brother Lou Xiaoqiang, a Chinese national who co-founded Pharmaron with his wife Zhang Bei and brother Boliang, also has a fortune worth estimated at more than $1 billion.

Pharmaron went public at the Shenzhen Stock Exchange in 2019, and later that same year listed in Hong Kong. From the Hong Kong IPO price of HK$39.50, the stock closed at HK$112.60 on Friday.

MORE FOR YOU

See related post:

The Doctors Are In: Cancer Experts Try To Boost Ailing U.S.-China Relations

@rflannerychina

You Might Also Like

Russia for Business: Experts Who Help Drive Decisions

The Quiet Shift in America’s Workforce: Why Side Hustles Are Becoming Essential for Women Over 40

Residing Paycheck to Paycheck: 9 Genius Methods To Cease It Ceaselessly – Dollarsanity

10 Tricks to Reside Frugally After Retirement – Dollarsanity

Tips on how to Price range Your Money Utilizing Dave Ramsey’s Budgeting Percentages – Dollarsanity

TAGGED:MoneyThe Forbes Journal
Share This Article
Facebook Twitter Email Copy Link Print
Marcus Rashford: England boss Thomas Tuchel sends warning to Barcelona loanee and urges him to not waste expertise
Sports

Marcus Rashford: England boss Thomas Tuchel sends warning to Barcelona loanee and urges him to not waste expertise

Thomas Tuchel says Marcus Rashford has the potential to turn out to be among the finest forwards in world soccer, however is anxious the Barcelona loanee may waste his expertise.The…

By Tycoon Herald 7 Min Read
Demi Lovato’s Crew Eyeing Attainable Tour After Followers Crash L.A. Present Queue
October 14, 2025
Madagascar’s president flees nation in worry for his life after army rebel
October 14, 2025
Mitt Romney’s Sister-in-Regulation Discovered Useless Close to SoCal Buying Mall
October 14, 2025
Martin Odegaard damage: Arsenal midfielder set to overlook one other six weeks with knee damage suffered in opposition to West Ham – Paper Speak
October 13, 2025

You Might Also Like

Joseph Safina’s Driven Becomes Amazon Bestseller, Blending High Finance with High Speeds
BusinessTrending

Joseph Safina’s Driven Becomes Amazon Bestseller, Blending High Finance with High Speeds

By Tycoon Herald 6 Min Read
How To Make A Funds: 12 Simple Methods To Do It (The Full Information) – Dollarsanity
Money

How To Make A Funds: 12 Simple Methods To Do It (The Full Information) – Dollarsanity

By Tycoon Herald 60 Min Read
10 Outdated-Normal Cleansing Suggestions from Grandma – Dollarsanity
Money

10 Outdated-Normal Cleansing Suggestions from Grandma – Dollarsanity

By Tycoon Herald 21 Min Read

More Popular from Tycoon Herald

MEET THE FATHER OF COADUNATE ECONOMIC MODEL
BusinessTrending

MEET THE FATHER OF COADUNATE ECONOMIC MODEL

By Tycoon Herald 2 Min Read
Woman Sentenced to 7 Days in Jail for Walking in Yellowstone’s Thermal Area

Woman Sentenced to 7 Days in Jail for Walking in Yellowstone’s Thermal Area

By Tycoon Herald
Empowering Fintech Innovation: Swiss Options Partners with Stripe to Transform Digital Payments
InnovationTrending

Empowering Fintech Innovation: Swiss Options Partners with Stripe to Transform Digital Payments

By Tycoon Herald 7 Min Read
Economy

Turkey’s central financial institution raises rate of interest to 46%

Unlock the Editor’s Digest at no costRoula Khalaf, Editor of the FT, selects her favorite tales…

By Tycoon Herald
Business

Hair Care Specialist Olaplex Notches Impressive Quarterly Results As A Newly Public Company

Olaplex, which launched an IPO last month, creates science-driven products for the hair. Courtesy of Olaplex…

By Tycoon Herald
Trending

U.S. Blew Up a C.I.A. Post Used to Evacuate At-Risk Afghans

A controlled detonation by American forces that was heard throughout Kabul has destroyed Eagle Base, the…

By Tycoon Herald
Leadership

Northern Lights: 17 Best Places To See Them In 2021

Who doesn’t dream of seeing the northern lights? According to a new survey conducted by Hilton, 59% of Americans…

By Tycoon Herald
Real Estate

Exploring Bigfork, Montana: A Little Town On A Big Pond

Bigfork, Montana, offers picturesque paradise in the northern wilderness. National Parks Realty With the melting of…

By Tycoon Herald
Leadership

Leaders Need To Know Character Could Be Vital For Corporate Culture

Disney's unique culture encourages young employees to turn up for work with smiles on their faces.…

By Tycoon Herald
The Tycoon Herald

Tycoon Herald: Your instant connection to breaking stories and live updates. Stay informed with our real-time coverage across politics, tech, entertainment, and more. Your reliable source for 24/7 news.

Company

  • About Us
  • Newsroom Policies & Standards
  • Diversity & Inclusion
  • Careers
  • Media & Community Relations
  • WP Creative Group
  • Accessibility Statement

Contact Us

  • Contact Us
  • Contact Customer Care
  • Advertise
  • Licensing & Syndication
  • Request a Correction
  • Contact the Newsroom
  • Send a News Tip
  • Report a Vulnerability

Terms of Use

  • Digital Products Terms of Sale
  • Terms of Service
  • Privacy Policy
  • Cookie Settings
  • Submissions & Discussion Policy
  • RSS Terms of Service
  • Ad Choices
© Tycoon Herald. All Rights Reserved.
Welcome Back!

Sign in to your account

Lost your password?